Enzo Biochem Inc (ENZ) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Enzo Biochem Inc (ENZ) has a cash flow conversion efficiency ratio of -0.074x as of April 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.22 Million) by net assets ($43.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check strategic asset allocation of Enzo Biochem Inc to assess the company's strategic physical and investment asset allocation.
Enzo Biochem Inc - Cash Flow Conversion Efficiency Trend (1989–2024)
This chart illustrates how Enzo Biochem Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. See ENZ net asset value for net asset value and shareholders' equity analysis.
Enzo Biochem Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Enzo Biochem Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Genenta Science SpA ADR
NASDAQ:GNTA
|
-0.077x |
|
ADX Energy Ltd
AU:ADX
|
-0.118x |
|
Lode Resources Ltd
AU:LDR
|
-0.055x |
|
Salee Printing Public Company Limited
BK:SLP
|
0.023x |
|
Sensen Networks Ltd
AU:SNS
|
-0.184x |
|
BR.SCH.ED.HLD.SP.ADR CL.A
F:BSK0
|
N/A |
|
Hindprakash Industries Limited
NSE:HPIL
|
0.004x |
|
Sigmaroc PLC
LSE:SRC
|
0.118x |
Annual Cash Flow Conversion Efficiency for Enzo Biochem Inc (1989–2024)
The table below shows the annual cash flow conversion efficiency of Enzo Biochem Inc from 1989 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Enzo Biochem Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-07-31 | $56.11 Million | $-26.26 Million | -0.468x | +0.70% |
| 2023-07-31 | $78.46 Million | $-36.98 Million | -0.471x | -54.71% |
| 2022-07-31 | $54.46 Million | $-16.59 Million | -0.305x | -5498.55% |
| 2021-07-31 | $68.59 Million | $387.00K | 0.006x | +101.92% |
| 2020-07-31 | $58.38 Million | $-17.18 Million | -0.294x | -626.72% |
| 2019-07-31 | $86.03 Million | $4.81 Million | 0.056x | +265.70% |
| 2018-07-31 | $81.12 Million | $-2.73 Million | -0.034x | -1361.62% |
| 2017-07-31 | $88.87 Million | $-205.00K | -0.002x | -100.39% |
| 2016-07-31 | $89.55 Million | $53.13 Million | 0.593x | +783.11% |
| 2015-07-31 | $42.61 Million | $-3.70 Million | -0.087x | -89.09% |
| 2014-07-31 | $36.95 Million | $-1.70 Million | -0.046x | +84.35% |
| 2013-07-31 | $34.13 Million | $-10.02 Million | -0.293x | -141.27% |
| 2012-07-31 | $49.10 Million | $-5.97 Million | -0.122x | -29.60% |
| 2011-07-31 | $88.72 Million | $-8.33 Million | -0.094x | +32.37% |
| 2010-07-31 | $97.02 Million | $-13.46 Million | -0.139x | -41.21% |
| 2009-07-31 | $116.78 Million | $-11.48 Million | -0.098x | -58.70% |
| 2008-07-31 | $138.29 Million | $-8.56 Million | -0.062x | -133.33% |
| 2007-07-31 | $141.89 Million | $-3.77 Million | -0.027x | +74.94% |
| 2006-07-31 | $95.59 Million | $-10.12 Million | -0.106x | -189.40% |
| 2005-07-31 | $108.27 Million | $12.83 Million | 0.118x | +321.11% |
| 2004-07-31 | $104.17 Million | $-5.58 Million | -0.054x | -148.36% |
| 2003-07-31 | $109.38 Million | $12.12 Million | 0.111x | +21.42% |
| 2002-07-31 | $104.73 Million | $9.56 Million | 0.091x | +11.29% |
| 2001-07-31 | $97.52 Million | $8.00 Million | 0.082x | +44.96% |
| 2000-07-31 | $87.18 Million | $4.93 Million | 0.057x | -61.47% |
| 1999-07-31 | $75.60 Million | $11.10 Million | 0.147x | +21.71% |
| 1998-07-31 | $68.80 Million | $8.30 Million | 0.121x | +0.27% |
| 1997-07-31 | $64.00 Million | $7.70 Million | 0.120x | +9.07% |
| 1996-07-31 | $55.30 Million | $6.10 Million | 0.110x | -25.94% |
| 1995-07-31 | $61.10 Million | $9.10 Million | 0.149x | +338.30% |
| 1994-07-31 | $51.20 Million | $-3.20 Million | -0.063x | -352.34% |
| 1993-07-31 | $32.30 Million | $800.00K | 0.025x | -61.08% |
| 1992-07-31 | $33.00 Million | $2.10 Million | 0.064x | +103.04% |
| 1991-07-31 | $1.10 Million | $-2.30 Million | -2.091x | -420.68% |
| 1990-07-31 | $12.70 Million | $-5.10 Million | -0.402x | -29.02% |
| 1989-07-31 | $15.10 Million | $-4.70 Million | -0.311x | -- |
About Enzo Biochem Inc
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development pro… Read more